Biopharmaceutical company Oculis Holding AG announced the appointment of Daniel Char to the role of chief legal officer.

Char joins Oculis from ImmunoGen where he served as chief legal officer and corporate secretary. From 2018 to 2022, he was the general counsel and corporate secretary of Evelo Biosciences.

Before that, he held legal positions of increasing seniority with several biotech and medical device companies, including Smith & Nephew, Targanta Therapeutics, and Biogen.

Topics